<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347522">
  <stage>Registered</stage>
  <submitdate>26/09/2011</submitdate>
  <approvaldate>27/10/2011</approvaldate>
  <actrnumber>ACTRN12611001125910</actrnumber>
  <trial_identification>
    <studytitle>Follow-up of children whose mothers participated in the DOMINO trial: does fish oil supplementation in pregnancy influence child development at 4 years?</studytitle>
    <scientifictitle>Does maternal supplementation with n-3 long-chain PUFA in pregnancy influence cognitive development in childhood?</scientifictitle>
    <utrn />
    <trialacronym>The DOMInO 4 Study</trialacronym>
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cognitive development</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>3 x 0.5 DHA rich Tuna Oil Capsules taken daily from 18-21 weeks until birth of child in The DOMInO Study.</interventions>
    <comparator>0.5g Blended Vegetable Oil Capsules</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive Developement, as assessed by the Differential Ability Scales, 2nd Edition (DASII).</outcome>
      <timepoint>4 years corrected age.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Language developement, as assessed by the CELF P - Clinical Evaluation of Language Fundamentals during Preschool years.</outcome>
      <timepoint>4 years corrected age.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Children who were included in the secondary outcome (neurodevelopment at 18months as assessed by the BSIDIII) of the original DOMInO Trial .</inclusivecriteria>
    <inclusiveminage>4</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central telephone and mail</concealment>
    <sequence>computer generated balanced variable blocks</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>18/06/2010</anticipatedstartdate>
    <actualstartdate>18/06/2010</actualstartdate>
    <anticipatedenddate>25/09/2010</anticipatedenddate>
    <actualenddate>25/09/2010</actualenddate>
    <samplesize>709</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>NH&amp;MRC</primarysponsorname>
    <primarysponsoraddress>National Health and Medical Research Council
GPO BOX 1421
CANBERRA  ACT  2601</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NH&amp;MRC</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO BOX 1421
CANBERRA  ACT  2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary aim is to determine whether supplementing pregnant women with DHA-rich capsules from 18-21 weeks of prengnacy until delivery will enhance the general cognitive ability of children at 4 years of age.

Hypothesis: Children whose mothers took DHA-rich fish oil capsules during the second half of pregnancy will have enhanced cognitive development at 4 years of age compared with children whose mothers consumed a placebo. 
This will be investigated using psychometric assessments.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Women's and Children's Health Network</ethicname>
      <ethicaddress>Women's and Children's Hospital
72 King William Rd
North Adelaide SA 5006</ethicaddress>
      <ethicapprovaldate>25/03/2010</ethicapprovaldate>
      <hrec>12/12/2242</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Maria Makrides</name>
      <address>Women's and Children's Health Research Institute
Level 7, CRB Women's and Children's Hospital
72 King William Road
North Adelaide  SA  5006
</address>
      <phone>+61 8 81616719</phone>
      <fax>+61 8 82390267</fax>
      <email>maria.makrides@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Helen Loudis</name>
      <address>Child Nutrition Research Centre
Flinders Medical Centre
Flinders Drive
BEDFORD PARK SA 5042</address>
      <phone>+61 8 82045515</phone>
      <fax>+61 8 82046296</fax>
      <email>helen.loudis@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Helen Loudis</name>
      <address>Child Nutrition Research Centre
Flinders Medical Centre
Flinders Drive
BEDFORD PARK SA 5042</address>
      <phone>+61 8 82045515</phone>
      <fax>+61 8 82046296</fax>
      <email>helen.loudis@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Maria Makrides</name>
      <address>Women's and Children's Health Research Institute
Level 7, CRB Women's and Children's Hospital
72 King William Road
North Adelaide  SA  5006
</address>
      <phone>+61 (0)8 8161 6067</phone>
      <fax>+61 (0)8 8239 0267</fax>
      <email>maria.makrides@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>